Disease and Therapy Review: Melanoma–Aarkstore Enterprise
The Melanoma Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide. Information on disease risk factors, identification, and staging, are also provided. Treatments options such as surgery, chemotherapy, radiation therapy, immunotherapy, and gene therapy are discussed. Dosing and treatment cost information is provided for the three approved melanoma treatments (Intron-A, Proleukin, and DTIC-Dome). The worldwide melanoma market size and sales data for Proleukin and Intron-A are also provided.
Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange’s Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
MELANOMA:
I. OVERVIEW
Risk factors
“ABCDEs” of identification and diagnosis
Types of melanoma
Severity and staging
II. INCIDENCE AND PREVALENCE
Incidence Table: (US, Canada, UK, France, Germany, Italy, Spain, Japan, China, India, Mexico, Worldwide)
Prevalence Table: (US, Canada, UK, France, Germany, Italy, Spain, Japan, China, India, Mexico, Worldwide)
III. TREATMENT
Chemotherapy
Radiation Therapy
Immunotherapy
Gene Therapy
IV. DOSING
Table: Dosing regimens of three approved melanoma treatments
V. TREATMENT COSTS
VI. MARKET SIZE
VII. COMMENTS
VIII. REFERENCES/RESOURCES
For more information, please visit :
http://www.aarkstore.com/reports/Disease-and-Therapy-Review-Melanoma-12814.html
Or email us at press@aarkstore.com or call +919272852585
Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers. Our customers include more than 700 leading financial institutions, professional service firms, consulting, law and accounting firms and other corporations throughout the world.